Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance

A Lin1, C H Nguy, F Shic

  • 1MR Spectroscopy Unit, Huntington Medical Research Institutes, 660 South Fair Oaks Avenue, Pasadena, CA 91105, USA.

Toxicology Letters
|October 20, 2001
PubMed

Insights

Methylsulfonylmethane (MSM) crosses the blood-brain barrier into the human brain. This alternative medicine was detected in subjects taking it, but not in others, with no observed adverse effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Medical Imaging

Background:

  • Methylsulfonylmethane (MSM) is a popular alternative medicine.
  • Its presence and effects within the human brain are not well understood.

Purpose of the Study:

  • To detect and quantify Methylsulfonylmethane (MSM) in the human brain using in vivo magnetic resonance spectroscopy (MRS).
  • To assess the blood-brain barrier (BBB) transfer of MSM.

Main Methods:

  • In vivo magnetic resonance spectroscopy (MRS) was employed.
  • MSM concentrations were measured in the brains of individuals who had ingested MSM and in control groups.

Main Results:

  • MSM was detected in all subjects who ingested it (0.42-3.40 mmole/kg brain), equally in gray and white matter.
  • MSM was undetectable in drug-naïve subjects, patients screened for toxic exposure, and those examined for Alzheimer's disease.
  • No adverse clinical or neurochemical effects were observed.

Conclusions:

  • MSM readily crosses the intact blood-brain barrier.
  • The presence of MSM in the brain was solely attributable to ingestion.
  • MSM has no known medical benefits despite its brain penetration.